Dr. William Irvin, MD
Claim this profileBon Secours Cancer Institute Richmond
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
5 reported clinical trials
13 drugs studied
Area of expertise
1Lung Cancer
Stage IV
PD-L1 positive
Stage III
2Non-Small Cell Lung Cancer
Stage IV
PD-L1 positive
Stage III
Affiliated Hospitals
Clinical Trials William Irvin, MD is currently running
Fianlimab + Cemiplimab
for Non-Small Cell Lung Cancer
This trial is testing a new drug combination for patients with advanced lung cancer. It aims to see if using two drugs together is more effective than one alone. The study also looks at side effects, how the drugs are processed in the body, and their impact on quality of life.
Recruiting0 awards Phase 2 & 3
Educational Video
for Cancer Understanding
This clinical trial tests whether a video intervention improves patient understanding of tumor genomic testing in patients with cancer that has spread to other parts of the body (metastatic). Measuring how the video intervention affects patient understanding of tumor genomic testing in patients with metastatic cancer may help doctors provide patient-centered care by effectively communicating the importance of tumor genomic testing.
Recruiting1 award N/A3 criteria
More about William Irvin, MD
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments William Irvin, MD has experience with
- Cemiplimab
- Placebo
- Fianlimab
- Pemetrexed
- Cisplatin
- Paclitaxel
Breakdown of trials William Irvin, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William Irvin, MD specialize in?
William Irvin, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are PD-L1 positive.
Is William Irvin, MD currently recruiting for clinical trials?
Yes, William Irvin, MD is currently recruiting for 3 clinical trials in Midlothian Virginia. If you're interested in participating, you should apply.
Are there any treatments that William Irvin, MD has studied deeply?
Yes, William Irvin, MD has studied treatments such as Cemiplimab, Placebo, Fianlimab.
What is the best way to schedule an appointment with William Irvin, MD?
Apply for one of the trials that William Irvin, MD is conducting.
What is the office address of William Irvin, MD?
The office of William Irvin, MD is located at: Bon Secours Cancer Institute Richmond, Midlothian, Virginia 23114 United States. This is the address for their practice at the Bon Secours Cancer Institute Richmond.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.